ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.

Kurt W Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.